Q1 2020 13F Holders as of 31 Mar 2020
-
Type / Class
-
Equity / Ordinary Shares, par value GBP 0.003 per share
-
Shares outstanding
-
792,553,191
-
Total 13F shares
-
3,279,730
-
Share change
-
+2,294,529
-
Total reported value
-
$3,419,000
-
Price per share
-
$1.04
-
Number of holders
-
8
-
Value change
-
+$2,078,837
-
Number of buys
-
4
-
Number of sells
-
6
Institutional Holders of Mereo BioPharma Group plc - Ordinary Shares, par value GBP 0.003 per share (MREO) as of Q1 2020
As of 31 Mar 2020,
Mereo BioPharma Group plc - Ordinary Shares, par value GBP 0.003 per share (MREO) was held by
8 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
3,279,730 shares.
The largest 8 holders included
BOXER CAPITAL, LLC, PRIMECAP MANAGEMENT CO/CA/, PERCEPTIVE ADVISORS LLC, CSS LLC/IL, Wealthspire Advisors, L.P., Sontag Advisory, LLC, UBS Group AG, and BANK OF AMERICA CORP /DE/.
This page lists
8
institutional shareholders reporting positions in this security
for the Q1 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.